| Nectar Lifescience Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532649 |
NSE Symbol : NECLIFE |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE023H01027 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 31.97 |
Market Cap(₹Cr) : 469.83 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 5.87 | 6.15 | 489.32 | 504.12 | 6.71 | 417.51 |
| Excise Duty | 0.87 | 0.92 | 60.41 | 49.79 | 0.99 | 58.66 |
| Net Sales | 5.00 | 5.23 | 428.91 | 454.33 | 5.73 | 358.85 |
| Other Operating Income | 0.71 | 0.01 | 1.79 | 0.65 | 0.01 | 0.45 |
| Other Income | 0.03 | 0.32 | 0.08 | 0.57 | 6.52 | 0.55 |
| Total Income | 5.74 | 5.56 | 430.77 | 455.56 | 12.25 | 359.85 |
| Total Expenditure | 181.72 | 68.63 | 585.00 | 410.27 | 6.32 | 319.50 |
| PBIDT | -175.98 | -63.07 | -154.23 | 45.28 | 5.93 | 40.35 |
| Interest | 0.00 | 0.00 | 17.67 | 17.12 | 0.00 | 19.98 |
| PBDT | -175.98 | -63.07 | -171.90 | 28.16 | 5.93 | 20.38 |
| Depreciation | 0.20 | 0.53 | 15.77 | 15.61 | 0.45 | 15.46 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.18 | -0.37 | -57.58 | 4.71 | -0.12 | 1.95 |
| Reported Profit After Tax | -176.01 | -63.23 | -130.09 | 7.84 | 5.60 | 2.97 |
| Extra-ordinary Items | -175.68 | -62.55 | 0.00 | 0.00 | 5.83 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.33 | -0.68 | -130.09 | 7.84 | -0.23 | 2.97 |
| EPS (Unit Curr.) | -7.84 | -2.82 | -5.80 | 0.35 | 0.25 | 0.13 |
| EPS (Adj) (Unit Curr.) | -7.84 | -2.82 | -5.80 | 0.35 | 0.25 | 0.13 |
| Calculated EPS (Unit Curr.) | -7.85 | -2.82 | -5.80 | 0.35 | 0.25 | 0.13 |
| Calculated EPS (Adj) (Unit Curr.) | -7.85 | -2.82 | -5.80 | 0.35 | 0.25 | 0.13 |
| Calculated EPS (Ann.) (Unit Curr.) | -31.39 | -11.28 | -23.20 | 1.40 | 1.00 | 0.53 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -31.39 | -11.28 | -23.20 | 1.40 | 1.00 | 0.53 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 22.43 | 22.43 | 22.43 | 22.43 | 22.43 | 22.43 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -3,519.60 | -1,205.93 | -35.96 | 9.97 | 103.49 | 11.24 |
| PBDTM(%) | -3,519.60 | -1,205.93 | -40.08 | 6.20 | 103.49 | 5.68 |
| PATM(%) | -3,520.20 | -1,208.99 | -30.33 | 1.73 | 97.73 | 0.83 |